Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy
Authors:
- Linda MolLMLinda Mol
- Cornelis J.A. PuntCPCornelis J.A. Punt
- 1 November 2011
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 47 (17) , 2560-2567
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Obesity Is an Independent Prognostic Variable in Colon Cancer SurvivorsClinical Cancer Research, 2010
- Impact of Body Mass Index and Weight Change After Treatment on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From Cancer and Leukemia Group B 89803Journal of Clinical Oncology, 2008
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studiesThe Lancet, 2008
- Body Mass Index and Outcomes in Patients Who Receive Adjuvant Chemotherapy for Colon CancerJNCI: Journal of the National Cancer Institute, 2006
- Overweight, obesity and cancer: epidemiological evidence and proposed mechanismsNature Reviews Cancer, 2004
- Impact of Body Mass Index on Outcomes and Treatment-Related Toxicity in Patients With Stage II and III Rectal Cancer: Findings From Intergroup Trial 0114Journal of Clinical Oncology, 2004
- Influence of body mass index on outcomes and treatment‐related toxicity in patients with colon carcinomaCancer, 2003
- Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. AdultsNew England Journal of Medicine, 2003
- The extent of the problem of obesityThe American Journal of Surgery, 2002
- Overweight, obesity, and cancer riskThe Lancet Oncology, 2002